Respiratory Distress Treatment Studie... ( Experts differ on what answers the re...)

Respiratory Distress Treatment Studies Conflict

Date:2/12/2008

Experts differ on what answers the research offers

TUESDAY, Feb. 12 (HealthDay News) -- Two new studies try to answer one of the most pressing questions in critical care medicine: How much pressure should be applied to keep open the partially collapsed lungs of people being treated for the deadly condition called acute respiratory distress syndrome?

Unfortunately, that question has not been definitively answered. Two experts have differing views on what the outcomes, which were not clear-cut, might mean. To one, the answer from the studies being published in the Feb. 13 issue of the Journal of the American Medical Association is that higher positive end-expiratory pressure (PEEP) is better, but the exact amount of pressure must be adapted to each person. Yet another contended there was no proof of the value of higher PEEP.

The results should have some impact on medical practice, pushing intensive care units toward use of higher PEEP levels, based on a patient's needs, said Dr. Derek C. Angus, chairman of the department of critical care medicine at the University of Pittsburgh, and author of an accompanying editorial.

The two research teams, from Canada and France, used different techniques to determine those needs. "The Canadian study titrated PEEP based on the reading of how oxygenated the lung tissue was," explained Angus. "The French relied on more sophisticated measures. One was slightly simpler than the other, but both were trying to convert a set of principles into a recipe to titrate PEEP, so you end with a different measure for each person."

Neither formula had a major effect on the death rate. In the French study of 767 people treated for acute respiratory distress syndrome (ARDS), the hospital mortality was 39 percent among those who got conventional treatment using relatively low PEEP, and 35.4 percent among those who got higher PEEP based on individual calculations. The comparable figu
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
4. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
5. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
6. Fire Season: Respiratory Health a Concern
7. Alpha-1 Foundation President to Give Keynote Address at 53rd Annual Respiratory Congress of the AARC Foundation and Activities
8. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
9. Recently discovered virus associated with pediatric respiratory tract infection in Germany
10. New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD
11. Kids Respiratory Virus Season Off and Running

Post Your Comments:

Respiratory Distress Treatment Studie...( Experts differ on what answers the re...),Health